{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T22:15:02Z","timestamp":1758924902963},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T00:00:00Z","timestamp":1485820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00063-016-0258-5","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T01:56:35Z","timestamp":1485827795000},"page":"99-104","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["NOAK: Real-life-Daten und Therapie von Blutungen mit\u00a0Antidots"],"prefix":"10.1007","volume":"112","author":[{"given":"H.","family":"Darius","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,31]]},"reference":[{"key":"258_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62343-0","author":"CT Ruff","year":"2013","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2013) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a\u00a0meta-analysis of randomised trials. Lancet. doi:\n                        10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"258_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1055\/s-0041-101750","volume":"140","author":"S Haas","year":"2015","unstructured":"Haas S, GARFIELD-AF (2015) Wie sieht die Versorgungssituation aus? Dtsch Med Wochenschr 140(Suppl. 1):S13\u2013S14. doi:\n                        10.1055\/s-0041-101750","journal-title":"Dtsch Med Wochenschr"},{"key":"258_CR3","doi-asserted-by":"publisher","unstructured":"Halvorsen S, Ghanima W, Tte IF, Hoxmark C, Falck P, Solli O, Jonasson C (2016) A\u00a0nationwide registry study to compare bleeding ratres in patients with atrial fibrillation being prescribed oral anticoagulants. Eur Heart J:17. doi:\n                        10.1093\/ehjcvp\/pvw031","DOI":"10.1093\/ehjcvp\/pvw031"},{"key":"258_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.5954","author":"DJ Graham","year":"2016","unstructured":"Graham DJ, Reichman ME, Wernecke M, Hsueh Y, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA (2016) Stroke, bleeding, and mortality risks in elderly Medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation. JAMA Intern Med. doi:\n                        10.1001\/jamainternmed.2016.5954","journal-title":"JAMA Intern Med"},{"key":"258_CR5","doi-asserted-by":"crossref","unstructured":"Pollack CV, Reilly PA, Eikelboom J et\u00a0al (2015) Idarucizumab for dabigatran reversal. N Engl J Med  373(6):511\u2013520","DOI":"10.1056\/NEJMoa1502000"},{"key":"258_CR6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510991","author":"DM Siegal","year":"2015","unstructured":"Siegal DM, Curnutte JT, Connolly SJ et\u00a0al (2015) Andexanet alpha for the reversal of factor Xa inhibitor activity. N Engl J Med. doi:\n                        10.1056\/NEJMoa1510991","journal-title":"N Engl J Med"},{"issue":"12","key":"258_CR7","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","volume":"375","author":"SJ Connolly","year":"2016","unstructured":"Connolly SJ, Milling TJ, Eikelboom JW et\u00a0al (2016) Andexanet alpha for acute major bleeding associated with factor Xa Andexanet alpha. N Engl J Med 375(12):1131\u20131141","journal-title":"N Engl J Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-016-0258-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-016-0258-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-016-0258-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T13:58:18Z","timestamp":1505138298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-016-0258-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,31]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1007\/s00063-016-0258-5","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,31]]}}}